據安迅思8月2日消息稱，印度阿達尼企業有限公司成立了一家全資石化子公司，標志著其進軍該行業。

　　阿達尼在上周末提交給孟買證券交易所(BSE)的一份監管文件中表示，該子公司名為阿達尼石油化工有限公司(APL)，將“繼續建立煉油廠、石化綜合企業、特種化學品單位、氫和相關化工廠和其他類似裝置的業務”。

　　APL 尚未投入運營。

　　2019年1月，阿達尼與德國化學公司巴斯夫簽署了一項協議，在古吉拉特邦西部的蒙德拉建立一個化學工廠。

　　2019年10月，該協議擴大到包括阿聯酋的阿布扎比國家石油公司和奧地利的北歐化工。

　　計劃中的化工綜合體總投資估計約為40億美元。

　　ADNOC在2019年表示，該項目將包括一個丙烷脫氫(PDH)工廠、一個聚丙烯(PP)裝置和一個由冰丙烯酸(GAA)、丁醇、2-乙基己醇(2-EH)、丙烯酸丁酯和其他下游產品組成的丙烯酸價值鏈。

　　然而，巴斯夫在2020年11月表示，由于新冠肺炎大流行，該項目被擱置。

　　阿達尼集團還計劃在蒙德拉建設一座年產200萬噸煤制聚氯乙烯(PVC)工廠。

　　這家印度企業集團在煤炭、物流、能源、農業、房地產、公共交通基礎設施等領域都有業務。

　　朱佳妮 摘譯自 安迅思

　　原文如下：

　　Indian conglomerate Adani Group to diversify into petrochemicals

　　India’s Adani Enterprises Ltd has incorporated a wholly-owned petrochemicals subsidiary to mark its foray into the business.

　　The subsidiary called Adani Petrochemicals Ltd (APL) will “carry on business of setting up refineries, petrochemicals complexes, specialty chemicals units, hydrogen and related chemical plants and other such similar units,” Adani in a regulatory filing to the Bombay Stock Exchange (BSE) over the weekend.

　　APL has yet to become operational.

　　In January 2019, Adani had signed an agreement with German chemical company BASF to set up a chemical complex at Mundra in western Gujarat state.

　　In October 2019, the deal was expanded to include UAE’s Abu Dhabi National Oil Company (ADNOC) and Austria’s Borealis.

　　Total investment for the planned chemical complex was estimated at around $4bn.

　　The complex will comprise a propane dehydrogenation (PDH) plant, a polypropylene (PP) unit and an acrylics value chain comprising glacial acrylic acid (GAA), butanol, 2-ethylhexanol (2-EH), butyl acrylate and other downstream products, according to ADNOC in 2019.

　　The project, however, was put on hold due to the Covid-19 pandemic, BASF had said in November 2020.

　　Adani Group also has plans to build a 2m tonne/year coal-to-polyvinyl chloride (PVC) plant at Mundra.

　　The Indian conglomerate has interests in coal, logistics, energy, agriculture, real estate, public transport infrastructure, among others.